Dehydroepiandrosterone Attenuates Study‐Induced Declines in Insulin Sensitivity in Postmenopausal Women

Annals of the New York Academy of Sciences

Volumn 774, Issue 1, 1995, Pages 291-293

  BATES, G WRIGHT ^a   EGERMAN, ROBERT S ^a   UMSTOT, EDWARD S ^a   BUSTER, JOHN E ^b   CASSON, PETER R ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROCORTISONE; INSULIN; PRASTERONE;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE TRANSPORT; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOCOMPETENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

EID: 0029556237     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb17389.x-i1     Document Type: Article

References (5)

1. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women
2. Replacement of dehydroepiandrosterone (DHEA) enhances T‐lymphocyte insulin binding in postmenopausal women
3. Case report: Amelioration of insulin resistance in diabetes with dehydroepiandrosterone
4. Enchanced post‐receptor insulin effects in women following dehydroepiandrosterone infusion
5. The minimal modeling method assessment of insulin sensitivity and B‐cell function in vivo